Immunome Inc Cash Flow Reinvestment Rate

Latest as of March 2023: 0.01x

Immunome Inc cash flow reinvestment rate. Immunome Inc (IMNM) has a Cash Flow Reinvestment Rate of 0.01x as of March 2023, reinvesting $212.00K (capex $106.00K plus investments $-106.00K) from operating cash flow of $24.17 Million. Explore IMNM debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$212.00K
Capex + Investments

Operating Cash Flow

$24.17 Million
USD

Capital Expenditures

$106.00K
USD

Immunome Inc Cash Flow Reinvestment Rate by Year (None–None)

Immunome Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Immunome Inc. For the full cash flow conversion analysis, see Immunome Inc cash conversion from operations.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow